Dementia, including dementia subtypes Nervous System Diseases
Conditions
Interventions
Staff in the care home, who are responsible for patient care, will use the West Wales Adverse Drug Reaction Profile for mental health between 1-5 times for each participant. Supporting scales will be
Sponsors
Swansea University (UK)
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Resident at the care home 2. Diagnosed with dementia or dementia subtypes 3. Currently taking at least one of: antipsychotic or anti-epileptic or antidepressant medicine 4. Willing and be able to give informed, signed consent themselves, or if capacity is lacking, guardian or representative willing to give consent to access the patient records
Exclusion criteria
Exclusion criteria: 1. Not be well enough to participate, as screened by their nurses 2. Those aged 18 or under
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Problems found and actions taken at each step in the trial. Each step is separated by one month and data will be collected using the ADR profile and case note review. | — |
Secondary
| Measure | Time frame |
|---|---|
| This project will be used to develop a feasibility study to assess: 1. Rates of recruitment, retention, compliance and cross-over 2. Feasibility of reporting changes in documentation for: 2.1. Amelioration of problems found using the profile 2.2. Problems found and actions taken using the profile 2.3. Medication review or changes 2.4. Patients with different severity of illness 3. Develop clinical endpoints for a full trial, such as measures to capture changes in patients? functioning 4. Calculate intra-cluster correlation coefficient (ICC), and any time delay to patient benefits 5. Explore the basis for cost-effectiveness analysis 6. Report views of care home staff on the WWADR profile for mental health medicines | — |
Countries
United Kingdom
Outcome results
None listed